MacroH2A suppresses the proliferation of the B16 melanoma cell line
Authors:
- 11 August 2014
- journal article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 10 (4) , 1845-1850
Abstract
MacroH2A is the most frequently altered histone, which participates in cancer progression. Increasing evidence demonstrates that cancer progression could be regulated by macroH2A by affecting the cell cycle. In the present study, it was demonstrated that macroH2A suppresses melanoma cell progression and the molecular mechanisms underlying this process were examined. The interference and overexpression vectors of macroH2A were constructed and then transferred into B16 melanoma cells and, following transfection, were analyzed by quantitative polymerase chain reaction (PCR), western blot analysis and immunofluorescence assays. Apoptosis and the cell cycle stage among all the treatment groups were detected. Then, cyclin D1, cyclin D3, cyclin-dependent protein kinase (CDK) 4, CDK6 and CDK8 expression was detected in order to elucidate the effects of macroH2A on cell cycle-related genes. The results demonstrated that the overexpression of macroH2A suppressed melanoma cell progression and arrested the cells in the G2/M stage. Furthermore, macroH2A inhibits cyclin D1, cyclin D2, CDK6 and CDK8 expression in B16 melanoma cells. In conclusion, the results demonstrated that macroH2A, a critical component of chromatin, suppresses the development of melanoma (which results from a disordered cell cycle) through regulating cyclin D1, cyclin D3 and CDK6 genes.Keywords
This publication has 34 references indexed in Scilit:
- QKI-Mediated Alternative Splicing of the Histone Variant MacroH2A1 Regulates Cancer Cell ProliferationMolecular and Cellular Biology, 2011
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- The histone variant macroH2A suppresses melanoma progression through regulation of CDK8Nature, 2010
- Cellular senescence predicts treatment outcome in metastasised colorectal cancerBritish Journal of Cancer, 2010
- CDK8 Is a Stimulus-Specific Positive Coregulator of p53 Target GenesMolecular Cell, 2007
- Transcription through chromatin by RNA polymerase II: Histone displacement and exchangeMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2007
- Heterochromatin and its Relationship to Cell Senescence and Cancer TherapyCell Cycle, 2007
- Senescence in premalignant tumoursNature, 2005
- Splicing regulates NAD metabolite binding to histone macroH2ANature Structural & Molecular Biology, 2005
- The language of covalent histone modificationsNature, 2000